An overview of the antimicrobial resistance mechanisms of bacteria

被引:1045
作者
Reygaert, Wanda C. [1 ]
机构
[1] Oakland Univ, Dept Biomed Sci, William Beaumont Sch Med, Rochester, MI 48063 USA
关键词
antimicrobial resistance; beta-lactamase; MRSA; ESBL; CRE;
D O I
10.3934/microbiol.2018.3.482
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Resistance to antimicrobial agents has become a major source of morbidity and mortality worldwide. When antibiotics were first introduced in the 1900's, it was thought that we had won the war against microorganisms. It was soon discovered however, that the microorganisms were capable of developing resistance to any of the drugs that were used. Apparently most pathogenic microorganisms have the capability of developing resistance to at least some antimicrobial agents. The main mechanisms of resistance are: limiting uptake of a drug, modification of a drug target, inactivation of a drug, and active efflux of a drug. These mechanisms may be native to the microorganisms, or acquired from other microorganisms. Understanding more about these mechanisms should hopefully lead to better treatment options for infective diseases, and development of antimicrobial drugs that can withstand the microorganisms attempts to become resistant.
引用
收藏
页码:482 / 501
页数:20
相关论文
共 89 条
[71]   Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm [J].
Soto, Sara M. .
VIRULENCE, 2013, 4 (03) :223-229
[72]   Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence [J].
Stefani, Stefania ;
Campanile, Floriana ;
Santagati, Maria ;
Mezzatesta, Maria Lina ;
Cafiso, Viviana ;
Pacini, Giovanni .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (03) :278-289
[73]   Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings [J].
Tacconelli, Evelina .
CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (04) :352-358
[74]   The multidrug resistance efflux complex, EmrAB from Escherichia coli forms a dimer in vitro [J].
Tanabe, Mikio ;
Szakonyi, Gerda ;
Brown, Katherine A. ;
Henderson, Peter J. F. ;
Nield, Jon ;
Byrne, Bernadette .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (02) :338-342
[75]   Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes [J].
Thiolas, A ;
Bornet, C ;
Davin-Régli, A ;
Pagés, JM ;
Bollet, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (03) :851-856
[76]   Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues [J].
Thomson, Kenneth S. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (04) :1019-1025
[77]   Class D β-lactamases do exist in Gram-positive bacteria [J].
Toth, Marta ;
Antunes, Nuno Tiago ;
Stewart, Nichole K. ;
Frase, Hilary ;
Bhattacharya, Monolekha ;
Smith, Clyde A. ;
Vakulenko, Sergei B. .
NATURE CHEMICAL BIOLOGY, 2016, 12 (01) :9-+
[78]   MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus [J].
Truong-Bolduc, QC ;
Dunman, PM ;
Strahilevitz, J ;
Projan, SJ ;
Hooper, DC .
JOURNAL OF BACTERIOLOGY, 2005, 187 (07) :2395-2405
[79]   Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms [J].
Van Acker, Heleen ;
Van Dijck, Patrick ;
Coenye, Tom .
TRENDS IN MICROBIOLOGY, 2014, 22 (06) :326-333
[80]   Characterization of mutations contributing to sulfathiazole resistance in Escherichia coli [J].
Vedantam, G ;
Guay, GG ;
Austria, NE ;
Doktor, SZ ;
Nichols, BP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) :88-93